Clinical Trials Directory

Trials / Unknown

UnknownNCT02375997

Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer

Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
592 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The majority of patients with newly diagnosed metastatic ESCC and gastric cancer patients experience a number of physical and psychosocial symptoms related to their cancer. Those patients endure the greatest level of distress from their disease relative to other cancer populations in China. Although new drugs have been applied in recent years, the median overall survival time of metastatic ESCC and GC patients are still around 12 months. Therefore, it is essential to maximize their quality of life (QOL) from the time of diagnosis. Multiple studies demonstrate that symptoms such as pain, fatigue, and anorexia are prevalent at diagnosis and worsen over time. As a result, suffering increases throughout the course of the illness. To be most effective, palliative care with intensive symptom management and psychosocial support should begin at the time of diagnosis, not once life-prolonging therapies have failed. And some studies have revealed that early palliative can even prolong the overall survival time in advanced lung cancer. The investigators then initiated a randomized phase III clinical trial with standard oncology care plus early palliative care or not in metastatic esophageal carcinoma and gastric cancer to observe whether the early palliative can improve the QOL and even prolong the overall survival time in those patients

Conditions

Interventions

TypeNameDescription
OTHERPalliative careEarly nutrition intervention and psychological intervention

Timeline

Start date
2014-10-01
Primary completion
2017-10-01
Completion
2018-10-01
First posted
2015-03-03
Last updated
2015-03-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02375997. Inclusion in this directory is not an endorsement.